Cancer Research Horizons

A quote reads: "GOSH Charity's renowned expertise, global network, and deep ties to patients will position C-Further to better collaborate on systemic challenges and improve outcomes for children and young people with cancer" - David Jenkinson, Head of childhood cancer, LifeArc

@goshcharity.bsky.social brings deep-rooted expertise, influential networks and strategic reach to the consortium – helping to grow C-Further’s impact and identify and fund new therapeutic opportunities.

🔗 Read more: bit.ly/4npqMA2

2/

A quote reads: "we want to do everything we can to give children the best chance, and best childhood possible" - Aoife Regan, Director of impact and charitable programmes at GOSH Charity.

🚨 We’re proud to welcome @goshcharity.bsky.social as a core partner in #CFurther, joining us and @lifearc.bsky.social in a £37m international effort to transform childhood cancer treatment.

GOSH Charity’s £10m commitment is its largest to date.

🔗 Read more: bit.ly/4npqMA2
1/

“Innovation is not an option; it’s a necessity.”
Dame Anna Dominiczak, Chief Scientist (Health), The Scottish Government

We’re excited to welcome the innovation and entrepreneurial community back this November for #InnovationSummit2025.

📅 18 November
📍 London
🔗RSVP: bit.ly/466wotD

Our #InnovationSummit2025 is coming to #London on 18 November 🚀

Join cancer researchers, entrepreneurs, and industry leaders to explore how to turn your discoveries into real-world impact.

💡 Learn from founders
🤝 Build your network
🎯 Explore translational pathways

Get your ticket: bit.ly/466wotD

A huge thank you to all #IEAwards25 winners and nominees for an inspiring evening. We can’t wait to see what’s next on your horizon.

Read more: bit.ly/44m94a0

#OnMyHorizon @anton-henssen.bsky.social, @nnennayakanu.bsky.social, @michellecruk.bsky.social @timwitney.bsky.social, @cuh.nhs.uk

🔬 Could ecDNA be a key to tackling aggressive cancers?

At our first On the Horizon event, experts from @cancergrand.bsky.social and Boundless Bio explored how ecDNA drives tumour evolution, and how it’s now being targeted in the clinic.

More: tinyurl.com/mrhzn894
@ucl.ac.uk #OnMyHorizon

🎉 Congrats to our scientists at The Scotland Institute on their publication in the Journal of Medicinal Chemistry!

They’ve developed reversible Ras inhibitors with tunable affinity for active & inactive forms, a big step in #DrugDiscovery.

More: tinyurl.com/y45t4yy7
#OnMyHorizon @acs.org

Proud to be part of the 3rd EWOC Europe Conference, a fantastic space for connection, growth and championing gender diversity in #chemistry.
Shout-out to @katherine-hazel.bsky.social for helping shape the event as part of the organising team!

Learn more: bit.ly/3V6FBee

#OnMyHorizon #EWOCEU25

Mentorship is powerful. Today we launch our Broadening Horizons programme at @wellcometrust.bsky.social !

We've heard from past mentors and now head to breakout sessions and networking. Thanks to everyone joining us in person and online! #OnMyHorizon

@juliana-c.bsky.social

It was great to hear from our CEO at #AACR2025 about how we can develop more effective, targeted therapeutics for children and young people with cancer, bringing more cures to clinic.

Learn more about #CFurther, our consortium with #LifeArc for #CYP cancers: www.c-further.org

After losing both parents to cancer, Pat LoRusso helped get 26 treatments approved and became #AACR president for 2024/25.

Read her thoughts on her career, #AACR25 and leading @cancerresearchuk.org 's New Agents Committee 👉 bit.ly/44thT21

@theaacr.bsky.social, @yalecancer.bsky.social, @yale.edu

Podcast promo for Cancer Research Horizons: “Partnerships to beat cancer.” Episode 6 features Curtis Asante and Matt Ashenden discussing how C-Further is driving innovation for childhood cancer. Includes a “Listen now” button and microphone icon.

Tackling childhood cancer takes strong partnerships 💪

In the latest “Partnerships to beat cancer” episode, we explore how #CFurther, our consortium for children and young people's cancers with #LifeArc, is driving innovation in this space.

🎧 Tune in: bit.ly/4lsJC9i

OncoStars ⋆ Panacea Stars A PanaceaStars-CRUK partnership to support academics and entrepreneurs translating their groundbreaking science to diagnose, treat and prevent cancer!

Calling all #CancerResearchers: the OncoStars programme, designed to support you in commercialising your research, is open for applications. Apply by 16 May for:

💡 Entrepreneurial training
🤝 Workshops, seminars and mentoring
🌐 Access to professional networks

Apply 👉: tinyurl.com/mr4672de

A quote card featuring a statement from Dave Kim, Senior Scientist at the Functional Genomics Centre. The quote reads: "We would be able to build more sophisticated models that can reduce the gap between lab research and clinical application – making cancer treatments more effective and accessible." Below the quote is a headshot of Dave Kim, a man in a suit, smiling. The Cancer Research Horizons logo is displayed in the bottom right corner.

What’s the best way to mimic the tumour microenvironment for drug discovery?

📰 In this Technology Networks article, Dave Kim, senior scientist at the Functional Genomics Centre, explores the pros and cons of different cell culture models, from cell lines to organoids.

Read more 👉 bit.ly/4jcV9aL

A great mentor can transform your #TranslationalResearch journey 🚀

We're excited to once again bring you the Broadening Horizons mentorship programme. Gain skills to make an impact beyond the lab with:

🤝 Expert mentors
🧠 Engaging events
💡 Inspiring talks

Apply by 30 April: bit.ly/3FUiYpf

Deadline extended 🚨 One more week to nominate for our #IEAwards25 👉https://bit.ly/4bejj1H

Boost your #TranslationalResearch project with up to £15K in #Funding, access to industry connections and showcase your work at our Awards ceremony.

Deadline: 24 March: #OnMyHorizon

🚨 Nominations for our #IEAwards25 close on 17 March!

If you're driving #TranslationalResearch, this is your chance to boost your project, gain funding & connect with industry leaders.

⏳Nominate yourself or a peer now: bit.ly/3CVCD7c

#OnMyHorizon

Innovation and Entrepreneurship Awards Our Awards celebrate researchers who are transforming ground-breaking discoveries into patient benefit. By spotlighting exceptional talent and ambition, we aim to inspire a new generation of innovator...

Know a woman entrepreneur turning ideas into patient benefit? Nominate her for our #IEAwards25 👉 bit.ly/429ofCN - only two weeks left!

Winners will receive:
💡 £5,000
🤝 Access to other entrepreneurs, industry experts and investors

Nominate yourself or a peer by 17 March ⏲

#OnMyHorizon

On #RareDiseaseDay, we look back at the achievements of our rare cancer trial DETERMINE.

DETERMINE is managed by the Centre for Drug Development, in partnership with @official-uom.bsky.social m.bsky.social, @unibirmingham.bsky.social and the Royal Marsden.

Read more 👉 bit.ly/3D9axpk

We're celebrating entrepreneurial researchers turning groundbreaking discoveries into patient benefit through our #IEAwards25 🏆 Is that you, or someone who inspires you?

Nominations close 17th March. Nominate yourself or a peer now 👉 bit.ly/3CVCD7c

#OnMyHorizon

Our key takeaways from #JPM2025:

🤝 M&As rise

🤖 #AI boosts drug discovery

🌎 Chinese #Innovation gains global recognition

Discover more insights 👉 bit.ly/4htaweG

#HealthcareInnovation, #AI, #OnMyHorizon

Thinking of submitting your #PediatricOncology project to #CFurther on 2 March?

Watch our on-demand webinar to discover what projects are in demand and how to craft a successful application.

Watch here: bit.ly/4hNX8BG

#OnMyHorizon

4 biotech leaders, 4 women, 4 stories.

To mark International Day of Women and Girls in Science, they share their journeys of co-founding and leading cutting-edge oncology start-ups while ensure the path to success is open to everyone 💡 bit.ly/42PF6KY

#OnMyHorizon #WomenInScience

Our new podcast, 'Partnerships to beat cancer', is all about the power of collaboration 💪

Listen to the first 2 episodes 👉 bit.ly/3ClY3dx and learn how we collaborate with commercial and academic partners to take on the challenges that no one else can.

#OnMyHorizon #ASAPCommunity

Apply by 13 January 🚨

Attention #PaediatricOncology researchers: our Translational Medicine Certificate Course offers interactive sessions, personalised mentoring and #sponsorship for up to 7 researchers.

Contact us to apply: entrepreneurial.programmes@cancer.org.uk
#OnMyHorizon

Image credit: Anne Weston, EM STP, The Francis Crick Institute

Scanning electron microscope image of pancreatic cancer cells, underneath which is the headline "Published in 'Molecular Cancer Therapeutics'" and the subheading "Autotaxin inhibitor IOA-289 suppresses pro-tumour signals in pancreatic cancer TME". The Cancer Research Horizons logo is present in the bottom left hand corner.

🚨 New publication alert! 🚨

Excited to share that first-in-class autotaxin inhibitor IOA-289 disrupts tumour-supporting signals in the pancreatic cancer TME.

Our colleagues published this study in collaboration with our portfolio company, iOnctura🌟

📰 Read more here: bit.ly/4f3RXvM

#OnMyHorizon

"Two decades of solid investments by the government has seen universities' tech transfer offices really competing with those in the United States".

Our Chief Business Officer, Tony Hickson, joined an insightful conversation about the future of the UK life sciences at #GenesisLondon24.

Collaboration update⭐
We've expanded our partnership with the Oncode Institute to include the Oncode Accelerator!

They bring new expertise to our shared mission of outsmarting cancer. Can’t wait to see what we accomplish together!

More👉 tinyurl.com/msn53xu2

#OnMyHorizon #AI #Organoids
📷: pbmedia

What's the next chapter for the UK life science ecosystem?

Tomorrow our very own Alessia Errico will take the stage at One Nucleus' "Building a World Class Life Science Ecosystem" panel. We’re looking forward to an insightful conversation!

#OnMyHorizon #Genesis2024